Surgical GBM
Showing 1 - 25 of >10,000
Spatiotemporal Dimensions of Metabolism in Autochthonous Tumors
Recruiting
- Glioblastoma Multiforme
- Surgical removal of the GBM tumor
- d4-NAM infusion
-
Orlando, FloridaAdventHealth Translational Research Institute
Sep 20, 2023
Glioma, Malignant, Glioblastoma, Glioblastoma Multiforme Trial in New York (Tissue autograft of pedicled temporoparietal fascial
Recruiting
- Glioma, Malignant
- +6 more
- Tissue autograft of pedicled temporoparietal fascial (TPF) or pericranial flap to bypass the blood brain barrier (BBB)
-
New York, New YorkLenox Hill Brain Tumor Center
Jul 13, 2023
Glioblastoma, GBM, Glioblastoma Multiforme Trial in Los Angeles, Boston, New York (Nivolumab-Placebo, Nivolumab,
Recruiting
- Glioblastoma
- +3 more
- Nivolumab-Placebo
- +4 more
-
Los Angeles, California
- +3 more
Jan 16, 2023
Glioblastoma Trial (Surgical tumor resection, GammaTile radiation therapy implantation, Stupp protocol (EBRT and Temozolamide))
Not yet recruiting
- Glioblastoma
- Surgical tumor resection, GammaTile radiation therapy implantation, Stupp protocol (EBRT and Temozolamide)
- (no location specified)
Apr 20, 2022
Glioblastoma, Glioblastoma Multiforme, GBM Trial in New York (Tissue autograft of pedicled temporoparietal fascial (TPF) or
Recruiting
- Glioblastoma
- +3 more
- Tissue autograft of pedicled temporoparietal fascial (TPF) or pericranial flap to bypass the blood brain barrier (BBB)
-
New York, New YorkLenox Hill Brain Tumor Center
Oct 27, 2021
Recurrent Glioblastoma, Glioblastoma - Category Trial in Edmonton (Repeat Surgical Management of Recurrent GBM)
Recruiting
- Recurrent Glioblastoma
- Glioblastoma - Category
- Repeat Surgical Management of Recurrent GBM
-
Edmonton, Alberta, CanadaUniversity of Alberta Division of Neurosurgery
Apr 5, 2022
Astrocytoma, Grade IV, Glioblastoma, Giant Cell Glioblastoma Trial in United States (CYNK-001 systemic and Intra cavity
Recruiting
- Astrocytoma, Grade IV
- +3 more
- CYNK-001 systemic and Intra cavity administration
-
Duarte, California
- +5 more
Jan 20, 2023
Glioblastoma, Recurrent Glioblastoma, GBM Trial in Philadelphia (drug, device, procedure)
Recruiting
- Glioblastoma
- +2 more
- Niraparib
- +2 more
-
Philadelphia, PennsylvaniaHospital of the University of Pennsylvania
Jul 16, 2021
Recurrent Glioblastoma, Recurrent Gliosarcoma, Recurrent Supratentorial Glioblastoma Trial in Los Angeles (drug, radiation,
Withdrawn
- Recurrent Glioblastoma
- +3 more
- Akt/ERK Inhibitor ONC201
- +2 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
May 10, 2021
Glioblastoma Multiforme, Anaplastic Glioma Trial in Houston (Vorinostat, Isotretinoin, Surgical Resection)
Active, not recruiting
- Glioblastoma Multiforme
- Anaplastic Glioma
- Vorinostat
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Oct 29, 2020
Brain and CNS Tumors Trial in United States (biological, drug, procedure)
Completed
- Brain and Central Nervous System Tumors
- HSPPC-96
- +2 more
-
San Francisco, California
- +8 more
Mar 23, 2021
Glioblastoma Trial in Bayamon, San Juan (Amyvid, Intravenous Solution)
Not yet recruiting
- Glioblastoma
- Amyvid, Intravenous Solution
-
Bayamon, Puerto Rico
- +1 more
Apr 18, 2023
Glioma, Glioma, Malignant, Glioblastoma Trial in New York (Laparoscopically harvested omental tissue autograft)
Recruiting
- Glioma
- +7 more
- Laparoscopically harvested omental tissue autograft
-
New York, New YorkLenox Hill Brain Tumor Center
Jul 31, 2023
GBM Trial in Nanjing (Postoperative radiotherapy for SVZ)
Recruiting
- GBM
- Postoperative radiotherapy for SVZ
-
Nanjing, Jiangsu, ChinaLining Guo
Oct 14, 2023
[18F]FPIA PET-CT in Glioblastoma Multiforme (GBM)
Recruiting
- Glioblastoma Multiforme of Brain
- Positron Emission Tomography-Computerised Tomography (PET-CT)
-
London, United KingdomImperial College Healthcare NHS Trust
Mar 23, 2023
Glioblastoma Evaluation for Heterogeneity In RadioseNsitivity
Recruiting
- Glioblastoma
- radiation of brain tissue specimen and dna damage analysis
-
Rozzano, Milan, ItalyHumanitas Clinical Institute
Oct 4, 2022
IRD at Admission Predicts Survival of GBM Patients -Prospective
Recruiting
- Glioblastoma Multiforme
-
Winnipeg MB, Manitoba, Canada
- +1 more
Jun 8, 2022
Glioblastoma Trial in Morgantown (Daratumumab)
Recruiting
- Glioblastoma
-
Morgantown, West VirginiaWest Virginia University Cancer Institute Mary Babb Randolph Can
Dec 5, 2022
Glioblastoma Trial in Boston (ITI-1001)
Not yet recruiting
- Glioblastoma
-
Boston, MassachusettsDana-Farber Cancer Institute
Jan 13, 2023
Glioblastoma Multiforme, Recurrent Glioblastoma Trial in United States (TheraSphere GBM)
Recruiting
- Glioblastoma Multiforme
- Recurrent Glioblastoma
- TheraSphere GBM
-
San Francisco, California
- +4 more
Aug 15, 2022
Glioblastoma, Adult Trial in Cleveland (Pembrolizumab at 7 days prior, Pembrolizumab at 14 days post, Pembrolizumab at 35 days
Recruiting
- Glioblastoma, Adult
- Pembrolizumab at 7 days prior
- +3 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 17, 2023
Glioblastoma (GBM) Trial in Basel (Advanced diffusion-weighted MRI (ADW-MRI))
Recruiting
- Glioblastoma (GBM)
- Advanced diffusion-weighted MRI (ADW-MRI)
-
Basel, SwitzerlandUniversity Hospital Basel
Jun 21, 2023
Glioblastoma, Adult Trial in United States (Paxalisib (GDC-0084))
Active, not recruiting
- Glioblastoma, Adult
- Paxalisib (GDC-0084)
-
Los Angeles, California
- +5 more
Aug 16, 2022
Glioblastoma Trial in Toronto (Focused Ultrasound (FUS) BBB Disruption)
Active, not recruiting
- Glioblastoma
- Focused Ultrasound (FUS) BBB Disruption
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Centre
Mar 28, 2022
Glioblastoma Multiforme Trial in Baltimore (Dichloroacetate (DCA), Genotype)
Recruiting
- Glioblastoma Multiforme
- Dichloroacetate (DCA)
- Genotype
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Aug 26, 2022